Molar, Third Clinical Trial
— 3TBAOfficial title:
An Early Feasibility Evaluation of a Novel 3rdMolarTooth Bud Ablation Procedure
NCT number | NCT05374993 |
Other study ID # | TP-015 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2022 |
Est. completion date | July 1, 2023 |
Verified date | April 2023 |
Source | TriAgenics Inc |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This single-arm prospective study will enroll a minimum of 7 and a maximum 10 subjects between the ages of 7 and 13 years of age with radiographic evidence of mandibular 3rd molar tooth bud development without enamel formation. Each subject will undergo a 3TBA procedure for each qualifying mandibular 3rd molar tooth buds. Each subject will receive treatment for qualifying mandibular tooth buds during the same session. Subjects will be followed for a minimum of 12 weeks post treatment.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 1, 2023 |
Est. primary completion date | July 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 7 Years to 13 Years |
Eligibility | Inclusion Criteria: 1. Subject is between 7 and 13 years of age 2. Subject has radiographic evidence of at least one mandibular 3rd molar tooth bud Exclusion Criteria: 1. Subject use of articaine is contraindicated (known hypersensitive to products containing sulfites). 2. Subject has any condition which, in the opinion of the Investigator, would prevent adequate performance of the procedure or affect the health and/or safety of the subject.- |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
TriAgenics Inc |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tooth Structure Development Assessment | Efficacy assessment will be performed based on periapical X-rays from Follow-up Visit 3 (12-week post treatment). Effectiveness Assessment will consist of evaluation of Tooth Structure Development and Bony Crypt In Growth using the following scale.
Tooth Structure Development Assessment Scale for 3rd Molar: "0" = No radiographic evidence. "1" = Minimal or trace level of detectable radiographic evidence. "2" = Moderate or intermediate level of detectable radiographic evidence of mineralized tooth structure formation with crown formation to be less than 50% complete. "3" = Advanced level of detectable radiographic evidence of mineralized tooth structure formation with enamel formation estimated to be 50% or more complete. Success is defined as a score of "0" or "1" on Tooth Structure Development scale at Follow-up Visit 3 (12-week post treatment). Each treated tooth bud is evaluated individually. |
12 weeks | |
Primary | Bony Crypt Growth Assessment | Efficacy assessment will be performed based on periapical X-rays from Follow-up Visit 3 (12-week post treatment). Effectiveness Assessment will consist of evaluation of Bony Crypt In Growth using the following scales.
Tooth Structure Development Assessment Scale for 3rd Molar: "0" = No radiographic evidence. "1" = Minimal or trace level of detectable radiographic evidence of mineralized tooth structure formation. "2" = Moderate or intermediate level of detectable radiographic evidence of mineralized tooth structure formation with crown formation to be less than 50% complete. "3" = Advanced level of detectable radiographic evidence of mineralized tooth structure formation with enamel formation estimated to be 50% or more complete. N/I = Not Interpretable. N/A = Not Applicable. Success is defined as a score of "0" or "1" on Bony Crypt Growth Assessment scales at Follow-up Visit 3 (12-week post treatment). Each treated tooth bud is evaluated individually. |
12 weeks | |
Secondary | Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] | Proximal second molars continue to erupt normally
Proximal second molars have no radiographic evidence of crown alteration Surgical site is completely healed over on visual exam Radiographic assessment of the surgical site is WNL expected or post op healing No adverse events related to the 3TBA procedure No reported neurological changes to tongue or lip |
12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05722509 -
Evaluation of a New Technique for Periodontal Pocket Reduction in the Extraction of Wisdom Teeth
|
N/A | |
Completed |
NCT05992233 -
"Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus"
|
N/A | |
Not yet recruiting |
NCT05924191 -
Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars
|
N/A | |
Recruiting |
NCT05923775 -
Pain and Trismus Control in Third Molar Surgery: Ibuprofen, Ketamine, and Their Combination
|
N/A | |
Completed |
NCT04182191 -
Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam
|
Phase 4 | |
Completed |
NCT04203771 -
Probiotic Intervention After Surgical Removal of Mandibular Third Molars
|
N/A | |
Not yet recruiting |
NCT06452134 -
Evaluation the Effect of Coenzyme Q10 on Tissue Healing Process in Patients Undergoing Wisdom Tooth Extraction
|
Phase 4 | |
Recruiting |
NCT05941130 -
3D Evaluation of Postoperative Edema After Third Molar Surgery
|
Phase 4 | |
Completed |
NCT04033744 -
Prevention of Mandibular Third Molar Extraction- Associated Periodontal Defects Using Platelet-Rich Fibrin
|
N/A | |
Completed |
NCT00154518 -
The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement
|
Phase 1 | |
Active, not recruiting |
NCT06073535 -
The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction
|
N/A | |
Completed |
NCT03545022 -
Acupuncture on Anxiety and Inflammatory Events Following Surgery of Mandibular Third Molars
|
N/A | |
Completed |
NCT02890680 -
Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery
|
N/A | |
Recruiting |
NCT02284841 -
Effect of Hilotherm Therapy on Post-operative Pain and Swelling Following Surgical Wisdom Tooth Removal
|
N/A | |
Recruiting |
NCT01896427 -
Comparing Pain and Swelling After Surgical Extraction of Mandibular Third Molar in Dexamethasone Injection and Without Corticosteroid Methods
|
Phase 4 | |
Enrolling by invitation |
NCT03567369 -
92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus
|
N/A |